The comparison of mutation types revealed that patients with larger deletions, encompassing the whole VHL gene, were less likely to present with ocular manifestations, whereas partial deletions and nonsense mutations, as well as missense mutations, often resulted in the development of a retinal hemangioblastoma. The gene discussed is VHL; the disease is retinal hemangioblastoma.